• Loading stock data...
PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » Tilray to start exporting medicinal pot to Germany

Tilray to start exporting medicinal pot to Germany

Al Restar by Al Restar
August 21, 2019
in Cannabis
2 min read
36
0
Tilray to start exporting medicinal pot to Germany

Photo by Rick Proctor on Unsplash

After a week of plummeting stock prices, Tilray TLRY, +1.91% picks up the pace after inking a deal to supply cannabis products to Europe through their new Portugal facility, the company announced Wednesday morning.

Tilray set on paper a deal with Cannamedical Pharma GmbH to export $3.3 million worth of cannabis to medical patients in Germany. The deal gives the pot company access to a powerful economy in a country with a population and gross domestic product that are twice the size of Canada.

In an interview, Tilray Chief Executive Brendan Kennedy said that deal with the German medical cannabis pharma company marks a move forward into Tilray’s global ambitions.

“Back in September of 2015, I set out in search of a license to cultivate, process, package, and distribute medical cannabis somewhere outside of Canada. We were the first Canadian [licensed producer] to have a license somewhere else in the world, and that was in Portugal, [which] issued their first THC cannabis cultivation license. And over the course of the last two years we have built out cultivation, the processing space, the manufacturing space in Portugal,” he said.

Tilray’s Portugal facility has started operation back in March of this year. The company prides that the facility measures 2.5 million square feet that including both cultivation and processing operations.

Last week, the weak performance of the broader market had also dragged the cannabis market down, especially Tilray, where stocks plummet after disclosing disappointing losses.

Tilray shares fell more than 12% after the company posted wider-than-expected quarterly losses. The disclosed number by the company outweighed better-than-expected revenue, failing to solicit support even from the most bullish analysts as they respond to the numbers.

In the second quarter of 2019, Tilray, which trades in NASDAQ, has seen a net loss of $35.1 million, or 36 cents a share, versus losses of $12 million, or 17 cents a share, in the year-ago period. Revenue, including excise taxes, rose to $45.9 million from $9.7 million in the year-ago period. After excise tax of $3.9 million, Tilray reported revenue of $42 million. 

Al Restar

Al Restar

An idealist straight from business school who works as a content marketer, digital branding consultant, and graphic designer. Outside work, he spends his time taking care of his cacti and painting watercolors.

Related Posts

Zenabis returned $1.9 million worth of pot  to Sundial over bad quality and visible molds
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
267
CannTrust stocks fell another 5% after weed distributor returned millions worth of pot
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
147
Cannabis stocks fell as possible recession brews
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
156
Hexo’s Stocks Continue To Suffer A Cannabis Stocks Dive
Cannabis

Aurora Cannabis hovers trade flat amid strong market

August 13, 2019
159
Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
128
CannTrust drags cannabis stocks further down as KPMG withdraws audit
Cannabis

CannTrust drags cannabis stocks further down as KPMG withdraws audit

August 9, 2019
147
Currently Playing

Subscribe To Our Newsletter

Ad

PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2020 PublicWire.com

Navigate Site

  • About
  • #96576 (no title)
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • #370 (no title)

© Copyright 2020 PublicWire.com

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Public Wire Logo

Hello please subscribe to our newsletter to get up to date news weekly!

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.